|
Volumn 58, Issue 8, 2015, Pages 3582-3592
|
Discovery of potent inhibitors of Schistosoma mansoni NAD+ catabolizing enzyme
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 METHYLFURAN 3 CARBOHYDRAZIDE;
2 METHYLFURAN 3 CARBOXYLIC ACID;
4 CHLORO 2 [5 (2 METHYLFURAN 3 YL) 1,3,4 OXADIAZOL 2 YL]PHENOL;
ANTISCHISTOSOMAL AGENT;
ENZYME INHIBITOR;
N (2 METHOXYPHENETHYL) 2 METHYLFURAN 3 CARBOXAMIDE;
N' (2 HYDROXY 3 METHYLBENZOYL) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (2 HYDROXY 3 METHYLBENZYLIDENE) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (2 HYDROXY 4 METHOXYBENZOYL) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (2 HYDROXY 4 METHOXYBENZYLIDENE) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (2 HYDROXY 4,6 DIMETHOXYBENZYLIDENE) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (2 HYDROXY 5 METHOXYBENZYLIDENE) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (2 HYDROXYBENZOYL) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (2 HYDROXYBENZYL) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (2 HYDROXYBENZYLIDENE) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (2 HYDROXYBENZYLIDENE) N,2 DIMETHYLFURAN 3 CARBOHYDRAZIDE;
N' (2 METHOXYBENZYL) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (2 METHOXYBENZYLIDENE) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (2 METHOXYBENZYLIDENE) N,2 DIMETHYLFURAN 3 CARBOHYDRAZIDE;
N' (2,3 DIHYDROXYBENZYLIDENE) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (2,4 DICHLORO 6 HYDROXYBENZYLIDENE) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (3 CHLORO 2 HYDROXYBENZYLIDENE) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (3,4 DIHYDROXYBENZYLIDENE) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' (5 CHLORO 2 HYDROXYBENZOYL) 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N' [3 (TERT-BUTYL) 2 HYDROXYBENZYLIDENE] 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N'[1 (2 HYDROXYPHENYL)ETHYLIDENE] 2 METHYLFURAN 3 CARBOHYDRAZIDE;
N(2 HYDROXYPHENETHYL) 2 METHYLFURAN 3 CARBOXAMIDE;
NICOTINAMIDE ADENINE DINUCLEOTIDE;
NICOTINAMIDE ADENINE DINUCLEOTIDE CATABOLIZING ENZYME INHIBITOR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTIPARASITIC AGENT;
CD38 ANTIGEN;
HELMINTH PROTEIN;
ADAPTIVE IMMUNITY;
ADULT;
ARTICLE;
CATALYSIS;
COMPETITIVE INHIBITION;
DRUG DETERMINATION;
DRUG POTENCY;
DRUG SCREENING;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME DEGRADATION;
HUMAN;
IMMUNE EVASION;
IN VITRO STUDY;
MOLECULAR DOCKING;
NEMATODE LIFE CYCLE STAGE;
NONHUMAN;
SCHISTOSOMA MANSONI;
SCHISTOSOMIASIS;
STRUCTURE ACTIVITY RELATION;
WORM TEGUMENT;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
CHEMISTRY;
DRUG EFFECTS;
ENZYMOLOGY;
METABOLISM;
PARASITOLOGY;
SCHISTOSOMIASIS MANSONI;
ANIMALS;
ANTIGENS, CD38;
ANTIPARASITIC AGENTS;
ENZYME INHIBITORS;
HELMINTH PROTEINS;
HUMANS;
MOLECULAR DOCKING SIMULATION;
NAD;
SCHISTOSOMA MANSONI;
SCHISTOSOMIASIS MANSONI;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84928494315
PISSN: 00222623
EISSN: 15204804
Source Type: Journal
DOI: 10.1021/acs.jmedchem.5b00203 Document Type: Article |
Times cited : (18)
|
References (19)
|